COVID-19 vaccines for adolescents offer a very high level of protection against infection, symptomatic disease, and severe disease



As of 30 January 2022, 70.9% of adolescents aged 15-17 years and 34.8% of 10-14 year-olds completed the primary course of COVID-19 vaccination, though with a broad range across EU/EEA countries. More than half of adolescents aged 10 to 17 in the EU/EEA have not yet completed a primary course.